Zelapar - 0187-0453-02 - (selegiline hydrochloride)

Alphabetical Index


Drug Information of Zelapar

Product NDC: 0187-0453
Proprietary Name: Zelapar
Non Proprietary Name: selegiline hydrochloride
Active Ingredient(s): 1.25    mg/1 & nbsp;   selegiline hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Zelapar

Product NDC: 0187-0453
Labeler Name: Valeant Pharmaceuticals International
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021479
Marketing Category: NDA
Start Marketing Date: 20060614

Package Information of Zelapar

Package NDC: 0187-0453-02
Package Description: 6 POUCH in 1 CARTON (0187-0453-02) > 1 BLISTER PACK in 1 POUCH > 10 TABLET in 1 BLISTER PACK

NDC Information of Zelapar

NDC Code 0187-0453-02
Proprietary Name Zelapar
Package Description 6 POUCH in 1 CARTON (0187-0453-02) > 1 BLISTER PACK in 1 POUCH > 10 TABLET in 1 BLISTER PACK
Product NDC 0187-0453
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name selegiline hydrochloride
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20060614
Marketing Category Name NDA
Labeler Name Valeant Pharmaceuticals International
Substance Name SELEGILINE HYDROCHLORIDE
Strength Number 1.25
Strength Unit mg/1
Pharmaceutical Classes Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA]

Complete Information of Zelapar


General Information